» Articles » PMID: 28982665

Human Induced Pluripotent Stem Cell-Derived Macrophages for Unraveling Human Macrophage Biology

Overview
Date 2017 Oct 7
PMID 28982665
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Despite a substantial appreciation for the critical role of macrophages in cardiometabolic diseases, understanding of human macrophage biology has been hampered by the lack of reliable and scalable models for cellular and genetic studies. Human induced pluripotent stem cell (iPSC)-derived macrophages (IPSDM), as an unlimited source of subject genotype-specific cells, will undoubtedly play an important role in advancing our understanding of the role of macrophages in human diseases. In this review, we summarize current literature in the differentiation and characterization of IPSDM at phenotypic, functional, and transcriptomic levels. We emphasize the progress in differentiating iPSC to tissue resident macrophages, and in understanding the ontogeny of in vitro differentiated IPSDM that resembles primitive hematopoiesis, rather than adult definitive hematopoiesis. We review the application of IPSDM in modeling both Mendelian genetic disorders and host-pathogen interactions. Finally, we highlighted the potential areas of research using IPSDM in functional validation of coronary artery disease loci in genome-wide association studies, functional genomic analyses, drug testing, and cell therapeutics in cardiovascular diseases.

Citing Articles

Synergy between pluripotent stem cell-derived macrophages and self-renewing macrophages: Envisioning a promising avenue for the modelling and cell therapy of infectious diseases.

Peng D, Li M, Yu Z, Yan T, Yao M, Li S Cell Prolif. 2024; 58(2):e13770.

PMID: 39537185 PMC: 11839195. DOI: 10.1111/cpr.13770.


Cardiac macrophages in maintaining heart homeostasis and regulating ventricular remodeling of heart diseases.

Kang M, Jia H, Feng M, Ren H, Gao J, Liu Y Front Immunol. 2024; 15:1467089.

PMID: 39372400 PMC: 11449765. DOI: 10.3389/fimmu.2024.1467089.


Plasma membrane abundance dictates phagocytic capacity and functional cross-talk in myeloid cells.

Winer B, Settle A, Yakimov A, Jeronimo C, Lazarov T, Tipping M Sci Immunol. 2024; 9(96):eadl2388.

PMID: 38848343 PMC: 11485225. DOI: 10.1126/sciimmunol.adl2388.


Macrophage cytotherapy on liver cirrhosis.

Ping D, Peng Y, Hu X, Liu C Front Pharmacol. 2024; 14:1265935.

PMID: 38161689 PMC: 10757375. DOI: 10.3389/fphar.2023.1265935.


iPSC-Derived Macrophages: The Differentiation Protocol Affects Cell Immune Characteristics and Differentiation Trajectories.

Klepikova A, Nenasheva T, Sheveleva O, Protasova E, Antonov D, Gainullina A Int J Mol Sci. 2022; 23(24).

PMID: 36555728 PMC: 9781144. DOI: 10.3390/ijms232416087.


References
1.
Panicker L, Miller D, Park T, Patel B, Azevedo J, Awad O . Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease. Proc Natl Acad Sci U S A. 2012; 109(44):18054-9. PMC: 3497826. DOI: 10.1073/pnas.1207889109. View

2.
Carcamo-Orive I, Hoffman G, Cundiff P, Beckmann N, DSouza S, Knowles J . Analysis of Transcriptional Variability in a Large Human iPSC Library Reveals Genetic and Non-genetic Determinants of Heterogeneity. Cell Stem Cell. 2016; 20(4):518-532.e9. PMC: 5384872. DOI: 10.1016/j.stem.2016.11.005. View

3.
Buchrieser J, James W, Moore M . Human Induced Pluripotent Stem Cell-Derived Macrophages Share Ontogeny with MYB-Independent Tissue-Resident Macrophages. Stem Cell Reports. 2017; 8(2):334-345. PMC: 5312255. DOI: 10.1016/j.stemcr.2016.12.020. View

4.
Choi K, Vodyanik M, Slukvin I . Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells. Nat Protoc. 2011; 6(3):296-313. PMC: 3066067. DOI: 10.1038/nprot.2010.184. View

5.
Sugimura R, Jha D, Han A, Soria-Valles C, Lummertz da Rocha E, Lu Y . Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature. 2017; 545(7655):432-438. PMC: 5872146. DOI: 10.1038/nature22370. View